ChEMBL logo

ChEMBL

spacer
ChEMBL Statistics
  Loading Statistics...
spacer

Compound Report Card

Compound Name and Classification

Compound ID CHEMBL2096647
CHEMBL2096647
Compound Name LANTHANUM CARBONATE
ChEMBL Synonyms LANTHANUM CARBONATE | FOSRENOL
Max Phase 4 (Approved)
Trade Names FOSRENOL
Molecular Formula C3La2O9

Sources

  • British National Formulary
  • Orange Book
  • Scientific Literature
  • USP Dictionary of USAN and International Drug Names
  • WHO Anatomical Therapeutic Chemical Classification

Molecule Features

CHEMBL2096647 compound icon
Drug Type:Synthetic Small Molecule Rule of Five:N First In Class:N Chirality:Unknown Prodrug:N Oral:Y Parenteral:N Topical:N Black Box:N Availability Type:Prescription-only

Mechanism of Action

Mechanism of Action ChEMBL Target References
Phosphate sequestering agent Phosphate FDA

Indications

MESH Heading MESH ID EFO ID EFO Term Max phase for indication References
Renal Insufficiency, ChronicD051436EFO:0003884chronic kidney disease3ClinicalTrials
Kidney DiseasesD007674EFO:0003086kidney disease2ClinicalTrials

Clinical Data

ClinicalTrials.gov LANTHANUM CARBONATE
The Cochrane Collaboration LANTHANUM CARBONATE

Compound Bioactivity Summary

Compound Assay Summary

Compound Target Summary

Compound Cross References

ATC V - VARIOUS
V03 - ALL OTHER THERAPEUTIC PRODUCTS
V03A - ALL OTHER THERAPEUTIC PRODUCTS
V03AE - Drugs for treatment of hyperkalemia and hyperphosphatemia
V03AE03 - lanthanum carbonate

ChemSpider ChemSpider Identifier not yet assigned
DailyMed lanthanum carbonate
spacer
spacer